Ly9 (CD229) cell-surface receptor is crucial for the development of spontaneous autoantibody production to nuclear antigens

Frontiers in Immunology

Volumn 4, Issue JUL, 2013, Pages

  de Salort, Jose ^a   Cuenca, Marta ^a   Terhorst, Cox ^b   Engel, Pablo ^a   Romero, Xavier ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Anti DNA autoantibodies; Disease susceptibility; Ly9 (CD229, SLAMF3); Murine Lupus; SLAMF; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CD 229; CELL NUCLEUS ANTIGEN; CELL SURFACE RECEPTOR; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIGEN; NUCLEOSOME AUTOANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELL ACTIVATION; CELL LINEAGE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NONHUMAN; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

EID: 84883730416     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00225     Document Type: Article

References (58)

1. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med (2008) 358:929-39. doi:10.1056/NEJMra071297
2. Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365:2110-21. doi:10.1056/NEJMra1100359
3. Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med (2012) 18:871-82. doi:10.1038/nm.2752
4. Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol (2010) 6:683-92. doi:10.1038/nrrheum.2010.176
5. Rai E, Wakeland EK. Genetic predisposition to autoimmunity - what have we learned?. Semin Immunol (2011) 23:67-83. doi:10.1016/j.smim.2011.01.015
6. Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A (2001) 98:1787-92. doi:10.1073/pnas.98.4.1787
7. Tsao BP, Cantor RM, Kalunian KC, Chen CJ, Badsha H, Singh R, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 99:725-31. doi:10.1172/JCI119217
8. Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 95:14869-74. doi:10.1073/pnas.95.25.14869
9. Wandstrat AE, Nguyen C, Limaye N, Chan AY, Subramanian S, Tian XH, et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity (2004) 21:769-80. doi:10.1016/j.immuni.2004.10.009
10. Wang A, Batteux F, Wakeland EK. The role of SLAM/CD2 polymorphisms in systemic autoimmunity. Curr Opin Immunol (2010) 22:706-14. doi:10.1016/j.coi.2010.10.014
11. Detre C, Keszei M, Romero X, Tsokos GC, Terhorst C. SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions. Semin Immunopathol (2010) 32:157-71. doi:10.1007/s00281-009-0193-0
12. Engel P, Eck MJ, Terhorst C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol (2003) 3:813-21. doi:10.1038/nri1202
13. Veillette A. Immune regulation by SLAM family receptors and SAP-related adaptors. Nat Rev Immunol (2006) 6:56-66. doi:10.1038/nri1761
14. Calpe S, Wang N, Romero X, Berger SB, Lanyi A, Engel P, et al. The SLAM and SAP gene families control innate and adaptive immune responses. Adv Immunol (2008) 97:177-250. doi:10.1016/S0065-2776(08)00004-7
15. Cannons JL, Tangye SG, Schwartzberg PL. SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol (2011) 29:665-705. doi:10.1146/annurevimmunol- 030409-101302
16. Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature (2008) 455:764 -9. doi:10.1038/nature07345
17. Cannons JL, Qi H, Lu KT, Dutta M, Gomez-Rodriguez J, Cheng J. Optimal germinal center responses require a multistage T Cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity (2010) 32:253-65. doi:10.1016/j.immuni.2010.01.010
18. Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and regulation of T follicular helper cells. J Exp Med (2012) 209:1241-53. doi:10.1084/jem.20120994
19. Hron JD, Caplan L, Gerth AJ, Schwartzberg PL, Peng SL. SH2D1A regulates T-dependent humoral autoimmunity. J Exp Med (2004) 200:261-6. doi:10.1084/jem.20040526
20. Chan AY, Westcott JM, Mooney JM, Wakeland EK, Schatzle JD. The role of SAP and the SLAM family in autoimmunity. Curr Opin Immunol (2006) 18:656-64. doi:10.1016/j.coi.2006.09.010
21. Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, et al. Follicular helper T cells are required for systemic autoimmunity. J Exp Med (2009) 206:561-76. doi:10.1084/jem.20081886
22. Linterman MA, Liston A, Vinuesa CG. T-follicular helper cell differentiation and the co-option of this pathway by non-helper cells. Immunol Rev (2012) 247:143- 59. doi:10.1111/j.1600-065X.2012.01121.x
23. Kumar KR, Li L, Yan M, Bhaskarabhatla M, Mobley AB, Nguyen C, et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science (2006) 312:1665-9. doi:10.1126/science.1125893
24. Brown DR, Calpe S, Keszei M, Wang N, McArdel S, Terhorst C, et al. Cutting edge: an NK cell-independent role for Slamf4 in controlling humoral autoimmunity. J Immunol (2011) 187:21-5. doi:10.4049/jimmunol.1100510
25. Keszei M, Latchman YE, Vanguri VK, Brown DR, Detre C, Morra M, et al. Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice. Int Immunol (2011) 23:149-58. doi:10.1093/intimm/dxq465
26. Sintes J, Vidal-Laliena M, Romero X, Tovar V, Engel P. Characterization of mouse CD229 (Ly9), a leukocyte cell surface molecule of the CD150 (SLAM) family. Tissue Antigens (2007) 70:355-62. doi:10.1111/j.1399-0039.2007.00909.x
27. Sayos J, Martin M, Chen A, Simarro M, Howie D, Morra M, et al. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. Blood (2001) 97:3867-74. doi:10.1182/blood.V97.12.3867
28. Romero X, Zapater N, Calvo M, Kalko SG, de la Fuente MA, Tovar V, et al. CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its Nterminal domain and relocalizes to the immunological synapse. J Immunol (2005) 174:7033-42.
29. Graham DB, Bell MP, McCausland MM, Huntoon CJ, van Deursen J, Faubion WA, et al. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. J Immunol (2006) 176:291-300.
30. Sintes J, Cuenca M, Romero X, Bastos R, Terhorst C, Angulo A, et al. Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+ T and invariant NKT cells. J Immunol (2013) 190:21-6. doi:10.4049/jimmunol.1202435
31. Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol (2009) 30(9):455-64. doi:10.1016/j.it.2009.06.003
32. Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G, et al. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest (1999) 103(12):1685-95. doi:10.1172/JCI5827
33. Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A (2000) 97:6670-5. doi:10.1073/pnas.97.12.6670
34. Dorner T, Giesecke C, Lipsky PE. Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther (2011) 13:243. doi:10.1186/ar3433
35. Vossenkamper A, Lutalo PM, Spencer J. Translational mini-review series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjogren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol (2012) 167:7-14. doi:10.1111/j.1365-2249.2011.04460.x
36. Lian ZX, Kita H, Okada T, Hsu T, Shultz LD, Dorshkind K, et al. Increased frequency of Pre-Pro B cells in the bone marrow of New Zealand Black (NZB) mice: implications for a developmental block in B cell differentiation. Dev Immunol (2002) 9:35-45. doi:10.1080/1044667021000003961
37. Carsetti R. Characterization of B-cell maturation in the peripheral immune system. Methods Mol Biol (2004) 271:25-35.
38. Chatterjee M, Hedrich CM, Rauen T, Ioannidis C, Terhorst C, Tsokos GC. CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances RORgammat recruitment to the IL17A promoter in human T lymphocytes. J Biol Chem (2012) 287:38168-77. doi:10.1074/jbc.M112.415067
39. Chatterjee M, Rauen T, Kis-Toth K, Kyttaris VC, Hedrich CM, Terhorst C, et al. Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J Immunol (2012) 188:1206-12. doi:10.4049/jimmunol.1102773
40. Martin M, Del Valle JM, Saborit I, Engel P. Identification of Grb2 as a novel binding partner of the signaling lymphocytic activation molecule-associated protein binding receptor CD229. J Immunol (2005) 174:5977-86.
41. Lee SK, Silva DG, Martin JL, Pratama A, Hu X, Chang PP, et al. Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity (2012) 37:880-92. doi:10.1016/j.immuni.2012.10.010
42. Carlucci F, Cortes-Hernandez J, Fossati-Jimack L, Bygrave AE, Walport MJ, Vyse TJ, et al. Genetic dissection of spontaneous autoimmunity driven by 129- derived chromosome 1 loci when expressed on C57BL/6 mice. J Immunol (2007) 178:2352-60.
43. Cruz-Munoz ME, Dong Z, Shi X, Zhang S, Veillette A. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nat Immunol (2009) 10:297-305. doi:10.1038/ni.1693
44. Keszei M, Detre C, Rietdijk ST, Munoz P, Romero X, Berger SB, et al. A novel isoform of the Ly108 gene ameliorates murine lupus. J Exp Med (2011) 208:811-22. doi:10.1084/jem.20101653
45. Ronnblom L, Elkon KB. Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol (2010) 6:339-47. doi:10.1038/nrrheum.2010.64
46. Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, Rolph MS, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol (2004) 173:68-78.
47. Zhou Z, Niu H, Zheng Y, And Morel L. Autoreactive marginal zone B cells enter the follicles and interact with CD4+ T cells in the lupus-prone mice. BMC Immunol (2011) 12:7. doi:10.1186/1471-2172-12-7
48. Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogeninduced lupus. J Immunol (2001) 167:1886-90.
49. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med (1999) 190:1697-710. doi:10.1084/jem.190.11.1697
50. Wither JE, Loh C, Lajoie G, Heinrichs S, Cai YC, Bonventi G, et al. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J Immunol (2005) 175:4309-19.
51. Atencio S, Amano H, Izui S, Kotzin BL. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J Immunol (2004) 172:4159-66.
52. Amano H, Amano E, Moll T, Marinkovic D, Ibnou-Zekri N, Martinez-Soria E, et al. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol(2003) 170:2293-301.
53. Pugh-Bernard AE, Cambier JC. B cell receptor signaling in human systemic lupus erythematosus. Curr Opin Rheumatol (2006) 18(5):451-5. doi:10.1097/01.bor.0000240353.99808.5f
54. Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res (2001) 3:136-41. doi:10.1186/ar290
55. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (1987) 236:944-7. doi:10.1126/science.3107127
56. Baudino L, Zeredoda SS, Nakata M, Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Semin Immunopathol (2006) 28:175-84. doi:10.1007/s00281-006-0037-0
57. Van Kaer L, Parekh VV, Wu L. Invariant natural killer T cells as sensors and mangers of inflammation. Trends Immunol (2013) 34:50-8. doi:10.1016/j.it.2012.08.009
58. Zeng D, Liu Y, Sidobre S, Kronenberg M, Strober S. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest (2003) 112:1211-22. doi:10.1172/JCI200317165